loader image
SSPC developing connections with Singapore
October 16, 2019

SSPC hosted a selection of Singapore’s A*Star Pharmaceutical Innovation Programme, known as the Pharma Innovation Progamme Singapore (PIPS), a partnership between the Agency for Science, Technology and Research (A*Star), the National University of Singapore (NUS), the Nanyang Technological University (NTU), the Singapore Institute of Technology (SIT), and pharma companies GlaxoSmithKline (GSK), MSD International GmbH (Singapore branch) and Pfizer Asia Pacific.

The group are providing a platform to build a well-connected pharma manufacturing ecosystem that catalyses collaboration and drives the strategic evolution of pharma manufacturing capabilities in Singapore. PIPS is also engaging other firms including multinationals, large local enterprises, and small and medium-sized enterprises that are “technology enablers” which can add value to the pharmaceutical manufacturing industry.

Share This:

Recent News